Viral safety of plasma-derived medicinal products with respect to hepatitis E virus - Scientific guideline

HumanScientific guidelines

This document addresses the viral safety of plasma-derived medicinal products with respect to hepatitis E virus. It discusses HEV reduction by specific manufacturing steps and risk assessment for these products.

Keywords: Hepatitis E virus, plasma-derived products, blood infectivity

Current effective version

Document history

Share this page